Celtaxsys
Celtaxsys has not claimed their Profile.
Want to better differentiate Celtaxsys between your competitors? Show buyers how.

Why does Celtaxsys win vs. PDS Biotechnology?
Show Celtaxsys's primary competitive advantage Show Celtaxsys's competitive differentiationCeltaxsys's alternatives and competitors
See how Celtaxsys compares to similar products. Celtaxsys's top competitors include PDS Biotechnology, Keryx Biopharmaceuticals, and Larimar Therapeutics.
PDS Biotechnology is a company with a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck ca…
Celtaxsys vs. PDS Biotechnology
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Keryx Biopharmaceuticals is working to identify medicines to advance the care of people with kidney disease. The company has assembled a concentration of kidney care, i…
Celtaxsys vs. Keryx Biopharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Larimar Therapeutics (Nasdaq: LRMR) is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, C…
Celtaxsys vs. Larimar Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Versartis is a biotechnology company developing therapeutics for the treatment of endocrine disorders. The company's lead product candidate is VRS-317, a once monthly f…
Celtaxsys vs. Versartis
View more in-depth data on:
- Competitors
- Products
- Customer References and more
VLST (Viral Logic Systems Technology) has developed a streamlined and efficient platform that rapidly yields biological therapeutic compositions of matter with a far gr…
Celtaxsys vs. VLST Corporation
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Taligen Therapeutics is a development-stage biotechnology company.In January 2011, Taligen Therapeutics was acquired by Alexion Pharmaceuticals. The valuation of Talige…
Celtaxsys vs. Taligen Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Logical Therapeutics is an early stage biotechnology company, developing medicines to treat diseases that are associated with poorly controlled or excessive inflammatio…
Celtaxsys vs. Logical Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Halsa Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of obesity, diabetes, cachexia and other metabolic diseases.
Celtaxsys vs. Halsa Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potentia…
Celtaxsys vs. American Stem Cell
View more in-depth data on:
- Competitors
- Products
- Customer References and more
ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures t…
Celtaxsys vs. ProtAffin
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatme…
Celtaxsys vs. Kylin Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- SE
SensiGen is a biotechnology company. They specialize creating tests to screen for diseases more efficiently and quickly. Their goal is to lower the overall costs of dia…
Celtaxsys vs. SensiGen
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- IN
Innodia Inc is a biotechnology company engaged in taking to the market drugs for the treatment of type 2 diabetes and related diseases and in generating value for its s…
Celtaxsys vs. Innodia
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Top 10 Celtaxsys competitors
You May Also Like
Halsa Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of obesity, diabetes, cachexia and other metabolic diseases.
Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties. Most protein pharmaceuticals are rapidly eliminated by the body, which limits their effectiveness and requires that they be administered by frequent, often daily, injection. The company's products are designed to last longer in the body, which aims to allow them to be administered less frequently, e.g., once per week to once per month, and maximizes their therapeutic benefits to patients. Company scientists combine protein structure/function information with targeted protein modification technologies to rationally design long-acting protein pharmaceuticals that, in many cases, are 10-100-fold more potent than competing products prepared using non-targeted protein modification technologies. Bolder BioTechnology has a robust pipeline of products in preclinical development, including products for the treatment of hematological and endocrine disorders, cancer and infectious disease. The company intend to commercialize these products independently and through strategic alliances with corporate partners.
REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat conditions such as allergies, autoimmune diseases and inflammatory disorders.
LeukoSight Inc. is an early stage biotechnology company developing a line of therapeutics that can be used to treat autoimmune and inflammatory diseases.

XOMA (NASDAQ: XOMA) is a biotechnology company focused on the discovery and development of monoclonal antibody-based therapeutics. The Company is a late-stage biotechnology company with a diverse portfolio of innovative therapeutic antibodies. XOMA's product candidates are the result of developing monoclonal antibodies, which have created new opportunities to potentially treat a wide range of endocrine diseases.

Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatment of many common diseases including cancer.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.